Mostrando 3 resultados de: 3
Filtros aplicados
Subtipo de publicación
Article(3)
Área temáticas
Enfermedades(3)
Cirugía y especialidades médicas afines(2)
Farmacología y terapéutica(2)
Medicina y salud(1)
Problemas sociales y servicios a grupos(1)
Nimotuzumab in combination with radiotherapy in high grade glioma patients: A single institution experience
ArticleAbstract: Nimotuzumab, a humanized antibody targeting epidermal growth factor receptor, has potent anti-prolifPalabras claves:Anaplastic astrocytoma, glioblastoma multiforme, High grade glioma, Monoclonal antibody, nimotuzumab, RadiotherapyAutores:Alert J., Chon I., Crombet-Ramos T., Jorrín E., Luaces P.L.o., Maria Teresa Solomon, Marinello J.J.u., Miranda N., Solomón M.T.e.Fuentes:scopusRadiotherapy plus nimotuzumab or placebo in the treatment of high grade glioma patients: results from a randomized, double blind trial
ArticleAbstract: BACKGROUND: The prognosis of patients bearing high grade glioma remains dismal. Epidermal Growth FacPalabras claves:Autores:Alert J., Bach F., Ballesteros J., Catala M., Crombet-Ramos T., de-Castro N., Domíngez R., Figueredo J., Griego M.G.o., Luaces P.L.o., Maria Teresa Solomon, Marinello J.J.u., Martell J.A.n., Nelson Quintanal, Patricia Luaces, Quintanal N., Salva S., Selva J.C.é., Solomón M.T.e., Toledo C., Vaquer J.Fuentes:scopusMortality from malignant brain tumors within the first 30 days after surgery
ArticleAbstract: Introduction: The neurological complications found in the high gradegliomas surgery are primarily rePalabras claves:Malignant gliomas, Mortality, Surgical resection gradeAutores:Crombet-Ramos T., Domínguez W., Pila Bandera M., Roig Fabre E., Solomón M.T.e.Fuentes:scopus